Sanofi (SNY) News Today $52.32 -1.22 (-2.28%) Closing price 04/25/2025 04:00 PM EasternExtended Trading$52.85 +0.53 (+1.01%) As of 04/25/2025 07:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period First Trust Advisors LP Raises Holdings in Sanofi (NASDAQ:SNY)First Trust Advisors LP boosted its stake in Sanofi (NASDAQ:SNY - Free Report) by 5.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 895,324 shares of the company's stock after purchasing an additional 44,027 sharesApril 26 at 4:56 AM | marketbeat.comSanofi Sales, Profit Beat Expectations on Higher Demand for Skin, Asthma DrugApril 25 at 2:39 PM | wsj.comMML Investors Services LLC Acquires 10,865 Shares of Sanofi (NASDAQ:SNY)MML Investors Services LLC grew its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 4.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 241,401 shares of the company's stock after buying aApril 25 at 5:23 AM | marketbeat.comNewEdge Advisors LLC Grows Stake in Sanofi (NASDAQ:SNY)NewEdge Advisors LLC increased its stake in Sanofi (NASDAQ:SNY - Free Report) by 19.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 36,796 shares of the company's stock after purchasing an additional 5,958 shares during tApril 25 at 4:14 AM | marketbeat.comSanofi reports Q1 IRFS EPS EUR 1.52 vs. EUR 0.91 last yearApril 24 at 9:36 PM | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Biogen (BIIB) and Sanofi (SNY)April 24 at 9:36 PM | markets.businessinsider.comSanofi 2025 Q1 - Results - Earnings Call PresentationApril 24 at 11:42 AM | seekingalpha.comFrench Drugmaker Sanofi Clocks 20% Q1 Profit Growth, Forecasts Strong Rebound In Annual ProfitApril 24 at 11:03 AM | benzinga.comPharma Giant Roche Tops First-Quarter Views; Sanofi's Sales Come In MixedApril 24 at 9:22 AM | investors.comSanofi Sales, Profit Beat Expectations on Higher Demand for Skin, Asthma DrugApril 24 at 4:48 AM | wsj.comSanofi (SNY) Surpasses Q1 Revenue Expectations; Strong Pharma and Vaccine Sales Drive GrowthApril 24 at 2:11 AM | gurufocus.comSanofi's quarterly profit beats estimates on Dupixent boost, newer productsApril 24 at 1:33 AM | reuters.comPress Release: Sanofi: strong Q1 performance and 2025 guidance confirmedApril 24 at 1:30 AM | globenewswire.comInnate Pharma regains rights to Anket, announces potential Sanofi investmentApril 23 at 5:58 PM | markets.businessinsider.comInnate Pharma Regains Rights on CD123 ANKET® and Announces Sanofi’s Strategic InvestmentApril 23 at 8:55 AM | tipranks.comSanofi (NASDAQ:SNY) Shares Purchased by Teachers Retirement System of The State of KentuckyTeachers Retirement System of The State of Kentucky boosted its holdings in Sanofi (NASDAQ:SNY - Free Report) by 7.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 409,290 shares of the company's stock afterApril 23 at 6:12 AM | marketbeat.comSanofi (NASDAQ:SNY) Shares Acquired by GeoWealth Management LLCGeoWealth Management LLC raised its position in shares of Sanofi (NASDAQ:SNY - Free Report) by 56.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 15,256 shares of the company's stock after acquiring anApril 23 at 5:00 AM | marketbeat.comNovartis and Sanofi CEOs say EU should raise drug prices in face of tariffsApril 23 at 2:44 AM | reuters.comSanofi’s Dupixent Gains FDA Approval for Chronic Spontaneous UrticariaApril 22, 2025 | tipranks.comCreativeOne Wealth LLC Invests $423,000 in Sanofi (NASDAQ:SNY)CreativeOne Wealth LLC purchased a new stake in Sanofi (NASDAQ:SNY - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 8,769 shares of the company's stock, valued at approximately $423,000. AApril 22, 2025 | marketbeat.comMariner LLC Acquires 8,107 Shares of Sanofi (NASDAQ:SNY)Mariner LLC grew its holdings in Sanofi (NASDAQ:SNY - Free Report) by 8.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 108,997 shares of the company's stock after purchasing an additionaApril 22, 2025 | marketbeat.comShort Interest in Sanofi (NASDAQ:SNY) Decreases By 28.7%Sanofi (NASDAQ:SNY - Get Free Report) was the recipient of a large drop in short interest in March. As of March 31st, there was short interest totalling 4,000,000 shares, a drop of 28.7% from the March 15th total of 5,610,000 shares. Based on an average trading volume of 2,730,000 shares, the short-interest ratio is presently 1.5 days. Approximately 0.2% of the shares of the stock are short sold.April 20, 2025 | marketbeat.comForum Financial Management LP Raises Holdings in Sanofi (NASDAQ:SNY)Forum Financial Management LP raised its position in Sanofi (NASDAQ:SNY - Free Report) by 76.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 66,827 shares of the company's stock after buying an additioApril 20, 2025 | marketbeat.comSanofi (NASDAQ:SNY) Shares Acquired by Callodine Capital Management LPCallodine Capital Management LP boosted its holdings in shares of Sanofi (NASDAQ:SNY - Free Report) by 5.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 384,189 shares of the company's stock after buying an additional 20April 20, 2025 | marketbeat.comBarclays PLC Buys 373,155 Shares of Sanofi (NASDAQ:SNY)Barclays PLC grew its position in Sanofi (NASDAQ:SNY - Free Report) by 58.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,012,927 shares of the company's stock after purchasing an additional 373,155April 20, 2025 | marketbeat.comZacks Research Has Bullish Forecast for Sanofi Q1 EarningsSanofi (NASDAQ:SNY - Free Report) - Equities researchers at Zacks Research raised their Q1 2027 earnings per share estimates for shares of Sanofi in a research note issued on Monday, April 14th. Zacks Research analyst K. Shah now forecasts that the company will post earnings of $1.12 per share foApril 19, 2025 | marketbeat.comAltshuler Shaham Ltd Invests $482,000 in Sanofi (NASDAQ:SNY)Altshuler Shaham Ltd bought a new stake in Sanofi (NASDAQ:SNY - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 10,000 shares of the company's stock, valued at approximately $482,000. A numberApril 19, 2025 | marketbeat.comSanofi (SNY) to Release Earnings on ThursdaySanofi (NASDAQ:SNY) will be releasing earnings before the market opens on Thursday, April 24, Financial Modeling Prep reports.April 19, 2025 | marketbeat.comRegeneron, Sanofi announce FDA approval of Dupixent for CSUApril 18, 2025 | msn.comRegeneron and Sanofi Announce FDA Approval of Dupixent for Chronic Spontaneous Urticaria in Patients Aged 12 and OlderApril 18, 2025 | quiverquant.comSanofi-Regeneron's Dupixent gets FDA's nod for skin conditionApril 18, 2025 | reuters.comPress Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticariaApril 18, 2025 | globenewswire.comSageView Advisory Group LLC Acquires Shares of 6,227 Sanofi (NASDAQ:SNY)SageView Advisory Group LLC bought a new position in shares of Sanofi (NASDAQ:SNY - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The fund bought 6,227 shares of the company's stock, valued at approximately $300,000. A number of other hedge funds and otheApril 18, 2025 | marketbeat.com9,716 Shares in Sanofi (NASDAQ:SNY) Acquired by Sagespring Wealth Partners LLCSagespring Wealth Partners LLC purchased a new stake in Sanofi (NASDAQ:SNY - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 9,716 shares of the company's stock, valued at approximately $469,April 18, 2025 | marketbeat.comEquities Analysts Set Expectations for Sanofi Q1 EarningsApril 18, 2025 | americanbankingnews.comBrokerages Set Sanofi (NASDAQ:SNY) Target Price at $62.50April 18, 2025 | americanbankingnews.comSanofi (NASDAQ:SNY) Coverage Initiated at BNP ParibasBNP Paribas started coverage on shares of Sanofi in a research report on Tuesday. They set an "outperform" rating and a $65.00 price objective on the stock.April 17, 2025 | marketbeat.comDodge & Cox Has $3.63 Billion Stake in Sanofi (NASDAQ:SNY)Dodge & Cox reduced its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 1.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 75,220,588 shares of the company's stock after selling 1,076,595 shares during the quarter. Sanofi makesApril 17, 2025 | marketbeat.comSanofi (NASDAQ:SNY) Receives Consensus Rating of "Buy" from AnalystsSanofi (NASDAQ:SNY - Get Free Report) has been assigned a consensus recommendation of "Buy" from the five research firms that are currently covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a hold rating, one has issued a buy rating and two have given a strong buyApril 17, 2025 | marketbeat.comRockefeller Capital Management L.P. Has $17.04 Million Position in Sanofi (NASDAQ:SNY)Rockefeller Capital Management L.P. cut its holdings in shares of Sanofi (NASDAQ:SNY - Free Report) by 2.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 353,245 shares of the company's stock after sellinApril 17, 2025 | marketbeat.comSanofi (SNY) Projected to Post Quarterly Earnings on ThursdayApril 17, 2025 | americanbankingnews.comDr. Reddy’s Laboratories Responds to Speculation on Sanofi’s Insulin Brand SaleApril 16, 2025 | tipranks.comSanofi Advances Respiratory Pipeline with New Asthma DataApril 16, 2025 | tipranks.comCauseway Capital Management LLC Raises Holdings in Sanofi (NASDAQ:SNY)Causeway Capital Management LLC increased its position in shares of Sanofi (NASDAQ:SNY - Free Report) by 38.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 690,436 shares of the company's stock after buyinApril 16, 2025 | marketbeat.comSanofi initiated with an Outperform at BNP Paribas ExaneApril 16, 2025 | markets.businessinsider.comSanofi Asthma Drug Misses Primary Goal, Plans For Pivotal StudyApril 15, 2025 | benzinga.comSanofi SA (SNY) in Dodge & Cox Stock Fund Q1 2024April 15, 2025 | gurufocus.comCrux Wealth Advisors Makes New Investment in Sanofi (NASDAQ:SNY)Crux Wealth Advisors bought a new stake in Sanofi (NASDAQ:SNY - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 6,396 shares of the company's stock, valued at approximately $308,000. Other instApril 15, 2025 | marketbeat.comBank of Montreal Can Has $11.46 Million Stock Position in Sanofi (NASDAQ:SNY)Bank of Montreal Can lessened its holdings in Sanofi (NASDAQ:SNY - Free Report) by 7.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 237,576 shares of the company's stock after selling 18,862 shares during the pApril 15, 2025 | marketbeat.comPress Release: Sanofi's respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPDApril 15, 2025 | globenewswire.com Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter. Email Address SNY Media Mentions By Week SNY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SNY News Sentiment▼1.181.03▲Average Medical News Sentiment SNY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SNY Articles This Week▼2915▲SNY Articles Average Week Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NVO News NVS News AZN News GSK News TAK News ARGX News BNTX News ONC News SMMT News TEVA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SNY) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanofi Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanofi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SNY Stock Free SNY Stock Alerts